These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9476121)

  • 1. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
    Emmerling MR; Spiegel K; Watson MD
    Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
    Zhou J; Fonseca MI; Pisalyaput K; Tenner AJ
    J Neurochem; 2008 Sep; 106(5):2080-92. PubMed ID: 18624920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
    Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
    J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
    Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
    Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of complement and contact system in Alzheimer's disease.
    Bergamaschini L; Donarini C; Gobbo G; Parnetti L; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):1971-83. PubMed ID: 11589915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.
    Webster S; Bradt B; Rogers J; Cooper N
    J Neurochem; 1997 Jul; 69(1):388-98. PubMed ID: 9202333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition.
    Fan R; DeFilippis K; Van Nostrand WE
    J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
    Loos M; Heinz HP
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():67-74. PubMed ID: 6375257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy.
    Wu T; Dejanovic B; Gandham VD; Gogineni A; Edmonds R; Schauer S; Srinivasan K; Huntley MA; Wang Y; Wang TM; Hedehus M; Barck KH; Stark M; Ngu H; Foreman O; Meilandt WJ; Elstrott J; Chang MC; Hansen DV; Carano RAD; Sheng M; Hanson JE
    Cell Rep; 2019 Aug; 28(8):2111-2123.e6. PubMed ID: 31433986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation.
    Webster SD; Tenner AJ; Poulos TL; Cribbs DH
    Neurobiol Aging; 1999; 20(3):297-304. PubMed ID: 10588577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early complement components in Alzheimer's disease brains.
    Veerhuis R; Janssen I; Hack CE; Eikelenboom P
    Acta Neuropathol; 1996; 91(1):53-60. PubMed ID: 8773146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.
    Veerhuis R; van der Valk P; Janssen I; Zhan SS; Van Nostrand WE; Eikelenboom P
    Virchows Arch; 1995; 426(6):603-10. PubMed ID: 7655742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of complement in Alzheimer's disease pathology.
    Emmerling MR; Watson MD; Raby CA; Spiegel K
    Biochim Biophys Acta; 2000 Jul; 1502(1):158-71. PubMed ID: 10899441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.